Insiders BIOLASE, Inc.

Equities

BIOL

US0909117022

Real-time Estimate Cboe BZX Other stock markets 09:56:59 2024-04-29 am EDT			5-day change	1st Jan Change
0.146 ^USD	-1.35%		-2.47%	-86.96%

Apr. 01	Ascendiant Capital Adjusts Biolase's Price Target to $4 From $15, Reiterates Buy Rating	MT
Mar. 22	Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dr. Carol Gomez Summerhays Intends to Resign as Member of the Board of Directors of Biolase, Inc	Dec. 29	CI
Biolase Names Russell Morrow Chief Dental Officer	22-10-13	MT
BIOLASE, Inc. Appoints Russell Morrow as Chief Dental Officer, Effective November 1, 2022	22-10-13	CI
Biolase Promotes Jennifer Bright to Chief Financial Officer, Steven Sandor to Chief Operating Officer	22-07-07	MT
BIOLASE, Inc. Announces Appointment of Jennifer Bright to Chief Financial Officer	22-07-07	CI
BIOLASE, Inc. Appoints Steven Sandor to Chief Operating Officer	22-07-07	CI
BIOLASE, Inc. Announces Election of Board of Directors	22-05-09	CI
BIOLASE Announces Board Changes	21-08-16	CI
BIOLASE, Inc. Announces Departure of Todd Norbe as Chief Executive Officer	21-03-17	CI
BIOLASE, Inc. Announces Departure of Todd Norbe as President and Member of the Board of Director	21-03-17	CI
John R. Beaver Promoted to President of BIOLASE	21-02-23	CI
BIOLASE, Inc. Appoints John R. Beaver as Chief Executive Officer	21-02-23	CI
BIOLASE, Inc. Appoints Michael DiTolla to its Board of Directors	19-11-15	CI
BIOLASE : Internationally Renowned Pediatric Dentist Appointed to BIOLASE Board of Directors	18-10-09	PU
BIOLASE, Inc. Appoints Elaine C. Wagner to Board of Directors	18-10-09	CI
BIOLASE Names Todd A. Norbe as President, Chief Executive Officer and Promotes John R. Beaver to Executive Vice President and Chief Financial Officer	18-08-08	CI
BIOLASE, Inc. Appoints Todd A. Norbe and Jess Roper to Board of Directors	18-06-19	CI
BIOLASE, Inc. Announces Management Changes	18-04-11	CI
Biolase, Inc. Appoints Garrett Sato to the Board, Member of the Audit, Compensation, and Nominating and Corporate Governance Committees	18-04-10	CI
Biolase, Inc. Appoints Richard B. Lanman to the Compensation Committee of the Board	17-11-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders BIOLASE, Inc.

Equities

BIOL

US0909117022

Insiders

Filters